ADRB2 and cardiovascular disorder: In view of the central importance of sympathetic hyperactivity in these cardiovascular diseases, the involvement of β2-AR/Giα signaling pathway in adverse vascular effects provides new insight into therapeutic approach for improvement of endothelial dysfunction and NO bioavailability.